Pregled bibliografske jedinice broj: 621948
Serum paraoxonase activities in endemic nephropathy patients on long-term hemodialysis.
Serum paraoxonase activities in endemic nephropathy patients on long-term hemodialysis. // Collegium Antropologicum 2006 ; 30(suppl.1)
Zagreb, Hrvatska, 2006. (poster, domaća recenzija, sažetak, ostalo)
CROSBI ID: 621948 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Serum paraoxonase activities in endemic nephropathy patients on long-term hemodialysis.
Autori
Tadijanović, Milena ; Rekić, B ; Simeon-Rudolf, V ; Baričić, Martin ; Juretić, Dubravka ; Miškić, Blaženka
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, ostalo
Izvornik
Collegium Antropologicum 2006 ; 30(suppl.1)
/ - , 2006
Skup
International Symposium »Recent Advances in Endemic Nephropathy«
Mjesto i datum
Zagreb, Hrvatska, 10.2006
Vrsta sudjelovanja
Poster
Vrsta recenzije
Domaća recenzija
Ključne riječi
Endemic nephropathy; hemodialysis
Sažetak
The aim of this study is to determine whether paraoxonase activity, paraoxonase phenotype and lipid status are altered in endemic nephropathy (EN) patients on long-term hemodialysis treatment as compared to healthy population. EN patients (n=31) and control subjects (n=145) were residents of the area of Slavonski Brod, Croatia. Paraoxon was used as a substrate for measuring basal and sodium chloride-stimulated (NaCl-stimulated) paraoxonase activity, and phenylacetate for measuring arylesterase activity. The double substrate method was used to assign phenotypes. Cholesterol, triglycerides, and high-density lipoprotein cholesterol (HDL-cholesterol) were determined by methods routinely used in medical- biochemical laboratories. Results are expressed as median values and tested by Mann-Whitney rank sum test. The values p<0.05 were considered significant. Basal and NaCl-stimulated paraoxonase activity as well as arylesterase activity were significantly lower in the patient group compared to controls ; 68% (p<0.001), 71% (p<0.001), and 58% (p<0.001), respectively. The distribution of paraoxonase phenotypes in the patient group and controls was as follows: AA, 45% and 39% ; AB, 37% and 48% ; BB 185 and 13%, respectively. Cholesterol and HDL-cholesterol were significantly decreased (87%, p<0.001 and 71% p<0.001, respectively), whereas triglycerides were significantly increased (195 %, p<0.001) in the patient group compared to control median value. We conclude that endemic nephropathy patients on long-term hemodialysis have decreased paraoxonase /arylesterase activity, which may indicate a greater risk of premature atherogenesis.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Ustanove:
Opća bolnica "Dr. Josip Benčević"
Profili:
Branka Rekić
(autor)
Dubravka Juretić
(autor)
Milena Tadijanović
(autor)
Blaženka Miškić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Social Science Citation Index (SSCI)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE